We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Craven House Capital Plc | LSE:CRV | London | Ordinary Share | GB00BD4FQ360 | ORD USD1.00 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.20 | 0.15 | 0.25 | 0.20 | 0.176 | 0.20 | 0.00 | 08:00:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | -5.26M | -5.52M | -1.4274 | -0.14 | 772.72k |
TIDMCRV
RNS Number : 2298K
Craven House Capital PLC
12 December 2018
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
Craven House Capital plc
("Craven House" or the "Company")
Reduction in Capital Update
The Company provides the following update in relation to the previously announced plans to apply to the High Court to undertake a Reduction in Capital:
The Court application has taken longer than originally anticipated and is now at an advanced stage, however the Directors have determined that it would be beneficial to utilise the current process to cancel the 155,958,824 deferred shares, made up of 77,979,412 deferred shares of GBP0.09 each in the capital of the Company with the 77,979,412 deferred shares of GBP0.009 each in the capital of the Company ("Deferred Shares").
These Deferred Shares are of negligible value to deferred shareholders and, under the articles of association of the Company, can be cancelled at any time for no consideration, via a Reduction in Capital.
A resolution proposing the cancellation of the Deferred Shares will be put to shareholders at a General Meeting to be held immediately after the upcoming Annual General Meeting. To ensure clarity is provided to the Court, the special resolutions previously passed on 24 August 2018 will be repeated in order for them to be voted on simultaneously.
The Company will therefore today post a Circular and Notice of General Meeting ("GM") to shareholders of the Company. The GM will be held at 10.45am on 4 January 2019, at 60 Cannon St, London, EC4N 6JP.
In the event that the resolutions proposed at the GM are approved by shareholders, the Court application will be updated and it is anticipated that the Capital Reduction will be approved by the Court by the end of January 2019.
Ends
For further information please contact:
Craven House Capital Plc Tel: 0203 286 8130 Mark Pajak www.Cravenhousecapital.com SI Capital Tel: 01483 413500 Broker Nick Emerson www.sicapital.co.uk SPARK Advisory Partners Limited Tel: 0203 368 3550 Nominated Adviser Matt Davis/Mark Brady www.Sparkadvisorypartners.com
About Craven House Capital:
The Company's Investing Policy is to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets globally in any geographic jurisdiction. The company will invest in both developed and developing markets providing long term patient capital and is often involved in special situations, restructuring, expansion and turn around investments in crisis and transitioning economies.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
UPDEAXAAFSXPFEF
(END) Dow Jones Newswires
December 12, 2018 03:00 ET (08:00 GMT)
1 Year Craven House Capital Chart |
1 Month Craven House Capital Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions